Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 Countries. CA Cancer J Clin 71:209–249
Indian Council of Medical Research. National Centre for Disease Informatics & Research, National Cancer Registry Programme, Report of National cancer registry Program 2020. Comparison of cancer incidence and patterns of all population based cancer registries. Accessed on 20 Dec 20 2020
Misra K, Patel S, Patel K, Ladwa M, Mehta R (2023) Incidental gallbladder carcinoma in routine cholecystectomy specimens at tertiary care hospital. Asian J Med Sci 14(10):246–250
Halaseh SA, Halaseh S, Shakman R (2022) A Review of the etiology and epidemiology of gallbladder cancer: what you need to know. Cureus 14(8):e2826
Shaffer EA (2009) Gallbladder cancer: the basics. Gastroenterol Hepatol 4(4):737–741
Lim K, Lee A, Jiang X, Teng T, Shelat V (2023) The link between Helicobacter pylori infection and gallbladder and biliary tract diseases: a review. Ann Hepatobiliary Pancreat Surg 27(3):241–250
Article PubMed PubMed Central Google Scholar
Wang L, Chen J, Jiang W, Cen L, Pan J, Yu C et al (2021) The relationship between helicobacter pylori infection of the gallbladder and chronic cholecystitis and cholelithiasis: a systematic review and meta-analysis. Can J Gastroenterol Hepatol. 2:1–11
Di Z, Guan W-B, Wang J-D, Zhang Y, Gong W et al (2013) A comparative study of clinicopathological features between chronic cholecystitispatients with and without Helicobacter pylori infection in gallbladder mucosa. PlosOne 8(7):e70265
Adami B, Tabatabaeian H, Ghaedi K et al (2019) MiR-146a is deregulated in gastric cancer. J Cancer Res Ther 15:108–114
Article PubMed CAS Google Scholar
Hanahan D (2022) Hallmarks of cancer: new directions. Cancer Discov 12:31–46
Article PubMed CAS Google Scholar
Fard G, Sasi AK, Abak A, Shoorei H, Khoshkar A, Taheri M (2021) Contribution of miRNAs in the pathogenesis of breast cancer. Front Oncol 11:768949
Vahabi M, Blandino G, Agostino SD (2021) MicroRNAs in head and neck squamous cell carcinoma: a possible challenge as biomarkers, determinants for the choice of therapy and targets for personalized molecular therapies. Transl Cancer Res 10:3090–3110
Article PubMed PubMed Central CAS Google Scholar
Das S, Hayden J, Sullivan T, Rieger-Christ K (2023) The roles of miRNAs in predicting bladder cancer recurrence and resistance to treatment. Int J Mol Sci 24:964
Article PubMed PubMed Central CAS Google Scholar
Chandra V, Kim J, Mittal B, Rai R (2016) MicroRNA aberrations: an emerging field for gallbladder cancer management. World J Gastroenterol 22(5):1787–1799
Article PubMed PubMed Central CAS Google Scholar
Fatima N, Srivastava AN, Nigam J, Raza ST, Rizvi S, Siddiqui Z (2019) Low expression of MicroRNA335–5p is associated with malignant behavior of gallbladder cancer: a clinicopathological study. Asian Pac J Cancer Prev 20(6):1895–1900
Article PubMed PubMed Central CAS Google Scholar
Qiu F, Yang L, Ling X, Yang R, Yang X, Zang L et al (2015) Sequence variation in mature microRNA-499 confers unfavorable prognosis of lung cancer patients treated with platinum-based chemotherapy. Clin Cancer Res 21(7):1602–1613
Article PubMed CAS Google Scholar
Ma YS, Shi BW, Lu HM, Xie PF, Xin R, Wu ZJ et al (2021) MicroRNA-499 serves as a sensitizer for lung cancer cells to radiotherapy by inhibition of CK2α-mediated phosphorylation of p65. Mol Ther Oncolyt 21:171–182
Wang J, Li J, Chen L, Fan Z, Cheng J (2020) MicroRNA-499 suppresses the growth of hepatocellular carcinoma by downregulating astrocyte elevated gene-1. Technol Cancer Res Treat 19:1533033820920253
PubMed PubMed Central CAS Google Scholar
Polakovicova I, Jerez S, Wichmann A, Sandoval-Bórquez A, Carrasco-Véliz N (2018) Role of microRNAs and exosomes in helicobacter pylori and epstein-barr virus associated gastric cancers. Front Microbiol. https://doi.org/10.3389/fmicb.2018.00636
Article PubMed PubMed Central Google Scholar
Peng HH, Zhang YD, Gong LS, Lui WD, Zang Y (2013) Increased expression of microRNA-335 predicts a favorable prognosis in primary gallbladder carcinoma. Onco Targets Ther 11:1625–1630
Edges SB, Compton CC (2010) The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol 17(6):1471–1474
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods 25(4):402–408
Article PubMed CAS Google Scholar
Li X, Wang L, Jia Z, Cui Q, Zhang C, Wang W et al (2013) MiR 499 regulates cell proliferation and apoptosis during late-stage cardiac differentiation via Sox6 and cyclin D1. PLoS ONE 8(9):e74504
Article PubMed PubMed Central CAS Google Scholar
Ueta E, Tsutsumi K, Kato H, Matsushita H, Shiraha H, Fujii M et al (2021) Extracellular vesicle-shuttled miRNAs as a diagnostic and prognostic biomarker and their potential roles in gallbladder cancer patients. Sci Rep 11:12298
Article PubMed PubMed Central CAS Google Scholar
Xue XY, Liu YX, Wang C, Gu XJ, Xue ZQ, Zang XL et al (2020) Identification of exosomal miRNAs as diagnostic biomarkers for cholangiocarcinoma and gallbladder carcinoma. Signal Transduct Target Ther 5:77
Article PubMed PubMed Central CAS Google Scholar
Buurman R, Gurlevik E, Schaffer V et al (2012) Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells. Gastroenterology 143(3):811–820
Article PubMed CAS Google Scholar
Díaz P, Valderrama MP, Bravo J, Quest AF (2018) Helicobacter pylori and gastric cancer: adaptive cellular mechanisms involved in disease progression. Front Microbiol 9:5
Article PubMed PubMed Central Google Scholar
Săsăran MO, Meliț LE, Dobru ED (2021) MicroRNA modulation of host immune response and inflammation triggered by Helicobacter pylori. Int J Mol Sci 22(3):1406
Article PubMed PubMed Central Google Scholar
Li M, Zhang S, Wu N, Wu L, Wang C, Lin Y et al (2016) Overexpression of miR 499 inhibits non-small cell lung cancer proliferation and metastasis by targeting VAV3. Sci Rep 14(6):23100
Li D, Zhu G, Di H, Li H, Lui X, Zhao M et al (2016) Associations between genetic variants located in mature microRNAs and risk of lung cancer. Oncotarget 7(27):41715–41724
Article PubMed PubMed Central Google Scholar
Zhang E, Xu Z, Duan W, Huang S, Lu L (2017) Association between polymorphisms in premiRNA genes and risk of oral squamous cell cancer in a Chinese population. PLoS ONE 12(6):e0176044
Article PubMed PubMed Central Google Scholar
Qiu D, Han F, Zhuang H (2018) MiR 499 rs3746444 polymorphism and hepatocellular carcinoma risk: a Meta analysis. J Can Res Ther 14:S490–S493
Li M, Zhang Q, Wu L, Jia C, Shi F, Li S et al (2014) Serum miR 499 as a novel diagnostic and prognostic biomarker in non-small cell lung cancer. Oncol Rep 31:1961–1967
Article PubMed CAS Google Scholar
Fatima N, Srivastava AN, Nigam J, Tandon N, Ahmad R, Kumar V (2019) Clinicopathological correlation of cancer stem cell markers Oct-4 and CD133 expression as prognostic factor in malignant lesions of gallbladder: an immunohistochemical study. Indian J Pathol Microbiol 62(3):384–390
Comments (0)